ASMB
NASDAQ · Biotechnology
Assembly Biosciences Inc
$24.97
-0.37 (-1.46%)
Open$25.41
Previous Close$25.34
Day High$25.78
Day Low$24.83
52W High$39.71
52W Low$20.23
Volume—
Avg Volume353.4K
Market Cap518.79M
P/E Ratio—
EPS$-0.16
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
-56.3% upside
Current
$24.97
$24.97
Target
$10.92
$10.92
$9.01
$10.92 avg
$17.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 133.99M | 44.93M | 300.07M |
| Net Income | -11,346,019 | -56,963,075 | 8.49M |
| Profit Margin | -8.5% | -133.8% | 2.8% |
| EBITDA | -22,218,335 | -67,781,254 | 15.38M |
| Free Cash Flow | — | — | 12.77M |
| Rev Growth | — | +65.8% | +3.4% |
| Debt/Equity | — | — | 0.84 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |